THE DAILY REPORT

Eli Lilly Settles First Lawsuit Alleging Link Between Pregnancy Drug, Breast Cancer

January 11, 2013 — Eli Lilly on Wednesday reached a settlement with four sisters who claimed they developed breast cancer as a result of a synthetic estrogen their mother took during pregnancy, AP/USA Today reports. The case is the first of many similar lawsuits to go to trial (Lavoie, AP/USA Today, 1/9).

The drug, called DES, was prescribed to pregnant women starting around 1938 to prevent miscarriages. In 1971, FDA told physicians to stop prescribing it after a study suggested an increased risk of a rare vaginal cancer years later among women whose mothers took the drug (Women's Health Policy Report, 1/10/11).

Thousands of lawsuits have been filed against companies that made or marketed DES that allege a link between the drug and vaginal cancer, cervical cancer and fertility problems.

Eli Lilly said that DES "did not cause the conditions alleged" in the sisters' lawsuit but that the settlement is in the company's "best interest." The financial terms of the settlement were not disclosed (AP/USA Today, 1/9).




The information contained in this publication reflects media coverage of women’s health issues and does not necessarily reflect the views of the National Partnership for Women & Families.

Search the Archives

Subscribe

RSS

The Editors

Debra Ness, publisher & president, National Partnership

Andrea Friedman, associate editor & director of reproductive health programs, National Partnership

Marya Torrez, associate editor & senior reproductive health policy counsel, National Partnership

Melissa Safford, associate editor & policy advocate for reproductive health, National Partnership

Perry Sacks, assistant editor & health program associate, National Partnership

Cindy Romero, assistant editor & communications assistant, National Partnership

Justyn Ware, editor

Amanda Wolfe, editor-in-chief

Heather Drost, Hanna Jaquith, Marcelle Maginnis, Ashley Marchand and Michelle Stuckey, staff writers

Tucker Ball, director of new media, National Partnership